Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
112 participants
OBSERVATIONAL
2020-03-05
2022-04-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
All consecutive eligible patients from all participating sites will be included in this clinical data collection. The relevant data of the coil embolization procedure will be collected via an eCRF system.
Peri procedural data on the coil embolization procedure as well as discharge, 30 days and at 3-6 months status will be collected.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
TRUfill®'s Line in Intracranial aNeurysm Embolisation
NCT01503775
Success in Comaneci-assist Coils Embolization Surveillance Study (SUCCESS)
NCT04518670
Coil Assisted Flow Diversion Safety and Performance Study
NCT04187573
Registry for Study of Coils in Intracranial Aneurysms
NCT01000675
Post-Market Clinical Follow-Up Study to Confirm Clinical Performance and Safety of the Codman Enterprise® 2 Vascular Reconstruction Device in the Endovascular Treatment of Intracranial Aneurysms
NCT02415010
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CascadeTM, Non-Occlusive Remodeling Net
Temporary assistance device for coil embolization of intracranial aneurysms
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Patient has been treated or planned to be treated with Cascade (Cascade device was opened).
2. Patient or patient's legally authorized representative or patient's family member (if approved by IEC) has signed and dated an Informed Consent Form (ICF), unless ICF is waived by local IEC.
3. Coil embolization procedure of intracranial aneurysm using temporary assisting device is initiated
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Perflow Medical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UH St. Ivan Rilski
Sofia, , Bulgaria
Medical Faculty of the Otto von Guericke University Magdeburg
Magdeburg, , Germany
radprax MVZ GmbH
Solingen, , Germany
Sheba Medical Center
Tel Litwinsky, , Israel
Central Clinical Hospital of the MSWiA
Warsaw, , Poland
Hospital Universitari De Bellvitge
Barcelona, , Spain
Hospital Universitari Vall D'Hebron
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CD0231
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.